Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 546

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer

Open access
Steele, Nina G., Carpenter, Eileen S., Kemp, Samantha B., Sirihorachai, Veerin R., The, Stephanie, Delrosario, Lawrence, Lazarus, Jenny, Amir, El-ad David, Gunchick, Valerie, Espinoza, Carlos, Bell, Samantha, Harris, Lindsey, Lima, Fatima, Irizarry-Negron, Valerie, Paglia, Daniel, Macchia, Justin, Chu, Angel Ka Yan, Schofield, Heather, Wamsteker, Erik-Jan, Kwon, Richard, Schulman, Allison, Prabhu, Anoop, Law, Ryan, Sondhi, Arjun, Yu, Jessica, Patel, Arpan, Donahue, Katelyn, Nathan, Hari, Cho, Clifford, Anderson, Michelle A., Sahai, Vaibhav, Lyssiotis, Costas A., Zou, Weiping, Allen, Benjamin L., Rao, Arvind, Crawford, Howard C., Bednar, Filip, Frankel, Timothy L., Pasca di Magliano, Marina·2020·Nature Cancer

Abstract

Pancreatic ductal adenocarcinoma (PDA) is characterized by an immune-suppressive tumor microenvironment that renders it largely refractory to immunotherapy. We implemented a multimodal analysis approach to elucidate the immune landscape in PDA. Using a combination of CyTOF, single-cell RNA sequencing and multiplex immunohistochemistry on patient tumors, matched blood and non-malignant samples, we uncovered a complex network of immune-suppressive cellular interactions. These experiments revealed heterogeneous expression of immune checkpoint receptors in individual patients’ T cells and increased markers of CD8+ T cell dysfunction in the advanced disease stage. Tumor-infiltrating CD8+ T cells had an increased proportion of cells expressing an exhausted expression profile that included upregulation of the immune checkpoint TIGIT, a finding that we validated at the protein level. Our findings point to a profound alteration of the immune landscape of tumors, and to patient-specific immune changes that should be taken into account as combination immunotherapy becomes available for pancreatic cancer. Using single-cell RNA sequencing, CyTOF and multiplex immunohistochemistry, Steele et al. survey the immune landscape in pancreatic cancers, adjacent tissue and blood, observing heterogeneous immune checkpoint receptor expression within patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-020-00121-4

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 546

Metadata

Authors
Steele, N. G., Carpenter, E. S., Kemp, S. B., Sirihorachai, V. R., The, S., Delrosario, L., Lazarus, J., Amir, E.-A. D., Gunchick, V., Espinoza, C., Bell, S., Harris, L., Lima, F., Irizarry-Negron, V., Paglia, D., Macchia, J., Chu, A. K. Y., Schofield, H., Wamsteker, E.-J., Kwon, R., Schulman, A., Prabhu, A., Law, R., Sondhi, A., Yu, J., Patel, A., Donahue, K., Nathan, H., Cho, C., Anderson, M. A., Sahai, V., Lyssiotis, C. A., Zou, W., Allen, B. L., Rao, A., Crawford, H. C., Bednar, F., Frankel, T. L., & Pasca di Magliano, M.
Venue
Nature Cancer
Published
2020-10-26
Volume
1
Issue
11
Pages
1097-1112
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3095442910
Cited by
546
References
66
FWCI
18.13
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. https://app.cochat.ai/papers/10.1038/s43018-020-00121-4
The paper
Steele, N. G., Carpenter, E. S., Kemp, S. B., Sirihorachai, V. R., The, S., Delrosario, L., Lazarus, J., Amir, E.-A. D., Gunchick, V., Espinoza, C., Bell, S., Harris, L., Lima, F., Irizarry-Negron, V., Paglia, D., Macchia, J., Chu, A. K. Y., Schofield, H., Wamsteker, E.-J., . . . Pasca di Magliano, M. (2020). Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nature Cancer. https://doi.org/10.1038/s43018-020-00121-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.